Use of radiation therapy in the last 30 days of life among a large population-based cohort of elderly patients in the United States

Journal of Clinical Oncology

Volumn 31, Issue 1, 2013, Pages 80-87

  Guadagnolo, B Ashleigh ^a   Liao, Kai Ping ^a   Elting, Linda ^a   Giordano, Sharon ^a   Buchholz, Thomas A ^a   Shih, Ya Chen Tina ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; COLORECTAL CANCER; ELDERLY CARE; FEMALE; HEALTH CARE COST; HOSPICE CARE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; RACE DIFFERENCE; TERMINAL CARE; UNITED STATES;

AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEALTH CARE COSTS; HOSPICE CARE; HUMANS; MALE; MEDICARE; NEOPLASMS; PROGNOSIS; RADIOTHERAPY; SEER PROGRAM; SURVIVAL RATE; UNITED STATES;

EID: 84871748592     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.45.0585     Document Type: Article

References (35)

1. Earle CC, Park ER, Lai B, et al: Identifying potential indicators of the quality of end-of-life cancer care from administrative data. J Clin Oncol 21:1133-1138, 2003
2. Earle CC, Landrum MB, Souza JM, et al: Aggressiveness of cancer care near the end of life: Is it a quality-of-care issue? J Clin Oncol 26:3860-3866, 2008
3. Earle CC, Neville BA, Landrum MB, et al: Evaluating claims-based indicators of the intensity of end-of-life cancer care. Int J Qual Health Care 17:505-509, 2005
4. Earle CC, Neville BA, Landrum MB, et al: Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol 22:315-321, 2004
5. Lutz S, Spence C, Chow E, et al: Survey on use of palliative radiotherapy in hospice care. J Clin Oncol 22:3581-3586, 2004
6. Gripp S, Mjartan S, Boelke E, et al: Palliative radiotherapy tailored to life expectancy in end-stage cancer patients: Reality or myth? Cancer 116:3251-3256, 2010
7. Hartsell WF, Scott CB, Bruner DW, et al: Randomized trial of short-versus long-course radiotherapy for palliation of painful bone metastases. J Natl Cancer Inst 97:798-804, 2005
8. Chow E, Harris K, Fan G, et al: Palliative radiotherapy trials for bone metastases: A systematic review. J Clin Oncol 25:1423-1436, 2007
9. Rades D, Dahm-Daphi J, Rudat V, et al: Is short-course radiotherapy with high doses per fraction the appropriate regimen for metastatic spinal cord compression in colorectal cancer patients? Strahlenther Onkol 182:708-712, 2006
10. Rades D, Lohynska R, Veninga T, al: Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients. Cancer 110:2587-2592, 2007
11. National Cancer Institute: Surveillance Epidemiology and End Results. http://seer.cancer.gov/index.html
12. Potosky AL, Riley GF, Lubitz JD, et al: Potential for cancer related health services research using a linked Medicare-tumor registry database. Med Care 31:732-748, 1993
13. Warren JL, Klabunde CN, Schrag D, et al: Overview of the SEER-Medicare data: Content, research applications, and generalizability to the United States elderly population. Med Care 40:IV-3-18, 2002 (suppl)
14. Jemal A, Siegel R, Xu J, et al: Cancer statistics, 2010. CA Cancer J Clin 60:277-300
15. Lutz S, Berk L, Chang E, et al: Palliative radiotherapy for bone metastases: An ASTRO evidence-based guideline. Int J Radiat Oncol Biol Phys 79:965-976, 2011
16. Prewett S, Venkitaraman R: Metastatic spinal cord compression: Review of the evidence for a radiotherapy dose fractionation schedule. Clin Oncol 22:222-230, 2010
17. Centers for Medicare & Medicaid Services: Quarterly index levels in the CMS Prospective Payment System (IPPS) hospital 2006 input price index using IHS Global Insight Inc. (IGI) forecast assumptions, by expense category: 1996-2021. https://www.cms.gov/MedicareProgramRatesStats/downloads/mktbskt-pps- hospital-2006.pdf
18. Centers for Medicare & Medicaid Services: Quarterly Index Levels in the CMS Medicare Economic Index using IHS Global Insight Inc. (IGI) Forecast Assumptions, by Expense Category: 1996-2021 https://www.cms.gov/ MedicareProgramRatesStats/downloads/mktbskt-economic-index.pdf
19. US Department of Health and Human Services, Health Resources and Services Administration, Bureau of Health Professions: Area Resource File (ARF), 2009-2010. www.arf.hrsa.gov
20. Charlson ME, Pompei P, Ales KL, et al: A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 40:373-383, 1987
21. Klabunde CN, Potosky AL, Legler JM, et al: Development of a comorbidity index using physician claims data. J Clin Epidemiol 53:1258-1267, 2000
22. Klabunde CN, Harlan LC, Warren JL: Data sources for measuring comorbidity: A comparison of hospital records and Medicare claims for cancer patients. Med Care 44:921-928, 2006
23. Klabunde CN, Legler JM, Warren JL, et al: A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients. Ann Epidemiol 17:584-590, 2007
24. Smith BD, Pan IW, Shih YC, et al: Adoption of intensity-modulated radiation therapy for breast cancer in the United States. J Natl Cancer Inst 103:798-809, 2011
25. Basu A, Rathouz PJ: Estimating marginal and incremental effects on health outcomes using flexible link and variance function models. Biostatistics 6:93-109, 2005
26. Tuttle TM, Jarosek S, Habermann EB, et al: Omission of radiation therapy after breast-conserving surgery in the United States: A population-based analysis of clinicopathologic factors. Cancer, 2011 http://www.ncbi.nlm.nih.gov/ pubmed/21952948
27. Steele CB, Pisu M, Richardson LC: Urban/rural patterns in receipt of treatment for non-small cell lung cancer among black and white Medicare beneficiaries, 2000-2003. J Natl Med Assoc 103:711-718, 2011
28. Johnston GM, Boyd CJ, Joseph P, et al: Variation in delivery of palliative radiotherapy to persons dying of cancer in Nova Scotia, 1994 to 1998. J Clin Oncol 19:3323-3332, 2001
29. Lavergne MR, Johnston GM, Gao J, et al: Variation in the use of palliative radiotherapy at end of life: Examining demographic, clinical, health service, and geographic factors in a population-based study. Palliat Med 25:101-110, 2011
30. Guadagnolo BA, Liu CC, Cormier JN, et al: Evaluation of trends in the use of intensity-modulated radiotherapy for head and neck cancer from 2000 through 2005: Socioeconomic disparity and geographic variation in a large population-based cohort. Cancer 116:3505-3512, 2010
31. Kapadia NS, Mamet R, Zornosa C, et al: Radiation therapy at the end of life in patients with incurable nonsmall cell lung cancer. Cancer 118:4339-4345, 2012
32. Rodrigues G, Videtic GMM, Sur R, et al: Palliative thoracic radiotherapy in lung cancer: An American Society for Radiation Oncology evidence-based clinical practice guideline. Pract Radiat Oncol 1:60-71, 2011
33. Rodrigues G, Macbeth F, Burmeister B, et al: Consensus statement on palliative lung radiotherapy: Third International Consensus Workshop on Palliative Radiotherapy and Symptom Control. Clin Lung Cancer 13:1-5, 2012
34. Emanuel EJ: Cost savings at the end of life. What do the data show? JAMA 275:1907-1914, 1996
35. Das M, Abdelmaksoud MH, Loo BW Jr, et al: Alternatives to surgery for early stage non-small cell lung cancer-ready for prime time? Curr Treat Options Oncol 11:24-35, 2010